<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879084</url>
  </required_header>
  <id_info>
    <org_study_id>2017-3170</org_study_id>
    <nct_id>NCT02879084</nct_id>
  </id_info>
  <brief_title>Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis</brief_title>
  <official_title>Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the variations in the retinal nerve fiber layer (RNFL) thickness&#xD;
      during uncomplicated anterior and intermediate uveitis, respectively. The objectives are to 1&#xD;
      ) confirm the RNFL thickening during an uncomplicated anterior uveitis as described in the&#xD;
      literature, 2) measure the RNFL thickness during an uncomplicated intermediate uveitis&#xD;
      specifically and 3) describe the variation in time of RNFL thickness during the two types of&#xD;
      uveitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty six individuals (18 with anterior uveitis and 18 with intermediate uveitis) will be&#xD;
      recruited at the Centre universitaire d'ophtalmologie du CHU de Québec. RNFL thickness will&#xD;
      be measured with optical coherence tomography at 3 times. For anterior uveitis, the RNFL&#xD;
      thickness will be measured at presentation, 1 week and 4 to 6 weeks. For intermediate&#xD;
      uveitis, the RNFL thickness will be measured at presentation, 4 to 6 weeks and 4 months. The&#xD;
      initial thickness will be studied for each type of uveitis and progression over time will be&#xD;
      studied also for each type of uveitis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">December 2020</completion_date>
  <primary_completion_date type="Actual">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retinal Nerve Fiber Layer Thickness in anterior uveitis</measure>
    <time_frame>At time 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Retinal Nerve Fiber Layer Thickness in intermediate uveitis</measure>
    <time_frame>At time 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Retinal Nerve Fiber Layer Thickness in anterior uveitis</measure>
    <time_frame>at 4 to 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Retinal Nerve Fiber Layer Thickness in intermediate uveitis</measure>
    <time_frame>at 4 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">36</enrollment>
  <condition>Anterior Uveitis</condition>
  <condition>Intermediate Uveitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult of 18 years old or more with anterior or intermediate uncomplicated uveitis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years old or more&#xD;
&#xD;
          -  anterior uncomplicated uveitis or intermediate uncomplicated uveitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of uveitis in the past, other than the actual uveitis&#xD;
&#xD;
          -  history of ophthalmologic pathology with potential impact on retinal nerve fiber layer&#xD;
             thickness&#xD;
&#xD;
          -  optic nerve or macular clinically apparent edema&#xD;
&#xD;
          -  history of glaucoma or other optic neuropathy&#xD;
&#xD;
          -  suspected or confirmed multiple sclerosis&#xD;
&#xD;
          -  ocular hypertension (intraocular pressure more than 22 mmHg)&#xD;
&#xD;
          -  reduced optical coherence tomography signal (lower than 7) on the Cirrus HD-OCT&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon Couture, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de recherche du CHU de Québec : Université Laval</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement. CHU de Québec</name>
      <address>
        <city>Québec</city>
        <zip>G1S 4LB</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 4, 2016</study_first_submitted>
  <study_first_submitted_qc>August 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2016</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Uveitis, Anterior</mesh_term>
    <mesh_term>Iridocyclitis</mesh_term>
    <mesh_term>Uveitis, Intermediate</mesh_term>
    <mesh_term>Pars Planitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

